Aigh Capital Management LLC Rvl Pharmaceuticals PLC Transaction History

Aigh Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.56 - $1.17 $78,254 - $163,495	-139,740 Reduced 11.12%	1,116,653 $625,000
Q1 2023 May 15, 2023	SELL	$1.02 - $1.39 $556,380 - $758,204	-545,471 Reduced 30.27%	1,256,393 $1.43 Million
Q4 2022 Feb 14, 2023	BUY	$1.02 - $1.61 $1.08 Million - $1.71 Million	1,062,333 Added 143.65%	1,801,864 $2.02 Million
Q3 2022 Nov 10, 2022	BUY	$1.28 - $2.91 $837,808 - $1.9 Million	654,538 Added 770.11%	739,531 $1.55 Million
Q2 2022 Aug 12, 2022	BUY	$1.21 - $1.81 $102,841 - $153,837	84,993 New	84,993 $116,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Aigh Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aigh Capital Management LLC with notifications on news.